InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Schwartz Phillip, Président de la R&D. Insider active across 1 company, notably Entera Bio Ltd.. Aggregated, 2 filings have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €45k. Activity tracked since 20 January 2022. The latest transaction was disclosed on 20 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
10,000 shares@ US$2.5250.036% mcap50.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000219:0
Ideal exit: 17 Oct 2022 (T+270)
10,000 shares@ US$2.5250.036% mcap100.0% of flowOrdinary Shares, par value NIS 0.0000769 per shareSEC:0001178913-22-000219
Ideal exit: 17 Oct 2022 (T+270)
2 of 2 declarations
About Schwartz Phillip
Phillip Schwartz is the President of R&D at Entera Bio Ltd. He oversees the company's research and development initiatives focused on innovation in the biotechnology field. His technical expertise is crucial for developing new therapies and supporting Entera Bio's mission.
